000 01401 a2200409 4500
005 20250515151939.0
264 0 _c20090318
008 200903s 0 0 eng d
022 _a1526-632X
024 7 _a10.1212/01.wnl.0000336916.38629.43
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDaumer, M
245 0 0 _aMRI as an outcome in multiple sclerosis clinical trials.
_h[electronic resource]
260 _bNeurology
_cFeb 2009
300 _a705-11 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article
650 0 4 _aAdult
650 0 4 _aCross-Sectional Studies
650 0 4 _aDisability Evaluation
650 0 4 _aGadolinium
650 0 4 _aHumans
650 0 4 _aImage Enhancement
650 0 4 _aLongitudinal Studies
650 0 4 _aMagnetic Resonance Imaging
_xstandards
650 0 4 _aMiddle Aged
650 0 4 _aMultiple Sclerosis
_xdiagnosis
650 0 4 _aMultiple Sclerosis, Chronic Progressive
_xdiagnosis
650 0 4 _aMultiple Sclerosis, Relapsing-Remitting
_xdiagnosis
650 0 4 _aOutcome Assessment, Health Care
_xmethods
650 0 4 _aRandomized Controlled Trials as Topic
700 1 _aNeuhaus, A
700 1 _aMorrissey, S
700 1 _aHintzen, R
700 1 _aEbers, G C
773 0 _tNeurology
_gvol. 72
_gno. 8
_gp. 705-11
856 4 0 _uhttps://doi.org/10.1212/01.wnl.0000336916.38629.43
_zAvailable from publisher's website
999 _c18526699
_d18526699